Serum 25‐Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case‐Control and Vitamin D Supplementation Substudy
Brain and Behavior · 2025-12 · 15 (12)
DOI: 10.1002/brb3.71095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 29.11.2025. Verfasst von Wan Linfang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics Department, Jingzhou First People's Hospital, Jingzhou, Hubei Province, China. Hauptthemen laut MEDLINE: Anxiety Disorders, Vitamin D Deficiency, Calcifediol, Vitamin D. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Research Project of the Education Department of Hubei Province.
Abstract (Originalsprache)
Objective
To investigate the correlation between serum 25‐hydroxyvitamin D3 (25‐(OH)D3) levels and anxiety disorders in adolescents, and to assess the potential impact of vitamin D status on pediatric anxiety disorders, thereby providing clinical evidence for diagnosis and treatment.
Methods
This study included 124 adolescents with anxiety disorders who visited the pediatric outpatient department of Jingzhou First People's Hospital from January 2020 to December 2022 as the experimental group and 131 healthy adolescents who underwent physical examinations during the same period as the control group. Serum 25‐(OH)D3 levels were compared between the two groups. Simple linear regression analysis was conducted to evaluate the predictive capacity of 25‐(OH)D3 levels on anxiety scores in the experimental group. Additionally, 86 adolescents with anxiety disorders and 25‐(OH)D deficiency or insufficiency in the experimental group received vitamin D supplementation for 12 weeks, and changes in anxiety scores before and after supplementation were analyzed to assess the effect of 25‐(OH)D3 levels on anxiety disorders.
Results
The mean serum 25‐(OH)D3 level in the experimental group [(16.48 ± 6.53) ng/ml] was significantly lower than that in the control group [(22.95 ± 7.25) ng/ml], with a statistically significant difference ( p < 0.05). The prevalence of vitamin D deficiency and insufficiency was higher in the experimental group (69.35%) than in the control group (36.64%), with a statistically significant difference ( p < 0.05). Furthermore, in the experimental group, anxiety scores were negatively correlated with serum 25‐(OH)D 3 levels, indicating that lower 25‐(OH)D 3 levels were associated with higher anxiety scores. After vitamin D supplementation, adolescents with anxiety disorders and 25‐(OH)D deficiency or insufficiency exhibited reduced anxiety scores.
Conclusion
Vitamin D deficiency may represent a potential risk factor for anxiety disorders in adolescents and demonstrate some predictive value for these conditions. Vitamin D supplementation could potentially alleviate anxiety symptoms in adolescents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatrics Department, Jingzhou First People's Hospital, Jingzhou, Hubei Province, China.
ORCID-Profile: Wan Linfang
Förderung
- Science and Technology Research Project of the Education Department of Hubei Province
Zitieren
APA
Linfang, W., & Yang, L. (2025). Serum 25‐Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case‐Control and Vitamin D Supplementation Substudy. Brain and Behavior, 15(12). https://doi.org/10.1002/brb3.71095
Vancouver
Linfang W, Yang L. Serum 25‐Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case‐Control and Vitamin D Supplementation Substudy. Brain and Behavior. 2025;15(12). doi:10.1002/brb3.71095
BibTeX
@article{Linfang2025,
author = {Linfang, Wan and Yang, Liu},
title = {Serum 25‐Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case‐Control and Vitamin D Supplementation Substudy},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {12},
doi = {10.1002/brb3.71095}
}
EUVIMED